Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. A urinary tract stent is a small tube that can be composed of metal, or polymer material and is inserted into the urinary tract to maintain luminal patency of the tract. GlobalData uses proprietary data and analytics to provide a comprehensive report on the urinary tract stents devices market, including market shares of different players within Spain. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the urinary tract stents market in Spain was Coloplast followed by Boston Scientific, Cook Group, Pnn Medical, Becton Dickinson and Co, Olympus, Applied Medical and SRS Medical Systems.
Ureteral Stents, Prostrate Stents, and Urethral Stents are tracked under this category.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the urinary tract stents devices market within Spain was expected to be over $4m in 2022.
For the latest complete market share analysis of urinary tract stents device market in Spain, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
